SS Innovations Welcomes “Father of Surgical Robotics,” Dr. Fredric Moll as Vice Chairman of the Board
SS Innovations, the developer of India’s first indigenous surgical robotic system dedicated to making advanced robotic surgeries cost-effective and accessible to a global population, announces that Dr. Frederic Moll, widely regarded as the “Father of Surgical Robotics” and the visionary founder of Intuitive Surgical, has joined SS Innovations International Inc. as Vice Chairman of the Board of Directors.
Dr. Moll brings a wealth of industry experience and expertise to the board. He oversaw the development and commercialization of the da Vinci surgical robotic system and most recently served as Chief Development Officer for Johnson & Johnson Medical Devices Companies from April 2019 to March 2023. Dr. Moll was a co-founder, Chairman, and Chief Executive Officer of Auris Health, Inc., a robotics medical device company acquired by Johnson & Johnson in 2019. He is also the Founding Partner of Sonder Capital Management, LLC, a healthcare venture capital investment firm. Additionally, he served on the board of Shockwave Medical, Inc. from March 2011 until its acquisition by Johnson & Johnson in May 2024. Dr. Moll was an early investor in Avra Medical Robotics and is a current investor in SS Innovations.
“The strength and caliber of Dr. Moll’s leadership are unparalleled, making him an invaluable addition to our Board of Directors,” said Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations. “His appointment comes at a pivotal moment as we experience unprecedented global growth. As a pioneer in robotic surgery, Dr. Moll brings a unique perspective and a wealth of experience that will guide both SS Innovations and the industry toward a promising future.”
Reflecting on his new role with gratitude and excitement, Dr. Fredric Moll said, “I am excited to contribute to SS Innovations’ mission of making robotic surgery accessible not only in the United States but across the globe. This technology should be available to everyone, and SS Innovations is uniquely positioned to achieve this goal. The company’s approach is both cost-effective and clinically advanced, offering capabilities in cardiac surgery and telesurgery that are unmatched. I look forward to working with the SS Innovations team to further these advancements and enhance the impact of our technology.”
SS Innovations is committed to making robotic surgeries cost-effective and accessible to a global audience. The company firmly believes in the widespread adoption of the SSI Mantra Surgical Robotic System and envisions a future where safe and affordable robotic surgeries are available across demographics, in India and abroad. SS Innovations takes pride in advancing India toward healthcare self-sufficiency, with the SSI Mantra empowering surgeons nationwide to perform complex surgeries at affordable rates.